Form D · Pharmaceuticals
COLUMBIA LABORATORIES INC
Livingston, NJ · CIK 0000821995
Offering snapshot reported Jul 15, 2010 · SEC filing
- Reported sold
- $24.5M Offering amount: $24.5M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $9.57K Reported outside-investor minimum
- First sale
- Jul 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2010 | Initial | $24,528,629 | No comparison | 25 | SEC filing |
| Jan 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 3, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145047
Only for purposes of this Form D, the shares of Common Stock are valued at $1.03 per share (the closing price on July 2, 2010) and the warrants are valued at $0.692 per warrant.
As more fully described in Columbia Laboratory, Inc.'s (the "Company") proxy statement, dated June 1, 2010, the Company paid Torreya Partners LLC a fee for investment banking services as described in that proxy statement.
Source: Form D, filed Jul 15, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Valerie L. Andrews | Director |
| Edward A. Blechschmidt | Director |
| Anthony R. Campbell | Director |
| Frank C. Condella | Director, Executive |
| James S. Crofton | Director |
| Lawrence A. Gyenes | Executive |
| Stephen G. Kasnet | Director |
| Michael Mc Grane | Executive |
| Selwyn P. Oskowitz, M.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
354 Eisenhower Parkway
Livingston, NJ, 07039
Livingston, NJ, 07039